IGC Pharma, Inc. (IGC)
0.3077
0.00 (0.00%)
USD |
NYAM |
Aug 26, 16:00
0.3063
0.00 (0.00%)
After-Hours: 20:00
IGC Pharma Total Liabilities (Quarterly) : 3.364M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.364M |
| March 31, 2026 | 3.064M |
| December 31, 2025 | 2.289M |
| September 30, 2025 | 1.651M |
| June 30, 2025 | 1.865M |
| March 31, 2025 | 2.417M |
| December 31, 2024 | 2.819M |
| September 30, 2024 | 2.992M |
| June 30, 2024 | 2.714M |
| March 31, 2024 | 2.581M |
| December 31, 2023 | 2.206M |
| September 30, 2023 | 2.408M |
| June 30, 2023 | 2.471M |
| March 31, 2023 | 2.267M |
| December 31, 2022 | 1.753M |
| September 30, 2022 | 1.814M |
| June 30, 2022 | 2.126M |
| March 31, 2022 | 2.942M |
| December 31, 2021 | 1.813M |
| September 30, 2021 | 2.58M |
| June 30, 2021 | 2.707M |
| March 31, 2021 | 3.064M |
| December 31, 2020 | 2.691M |
| September 30, 2020 | 2.748M |
| June 30, 2020 | 3.436M |
| Date | Value |
|---|---|
| March 31, 2020 | 2.447M |
| December 31, 2019 | 1.316M |
| September 30, 2019 | 1.645M |
| June 30, 2019 | 1.085M |
| March 31, 2019 | 0.893M |
| December 31, 2018 | 0.598M |
| September 30, 2018 | 2.743M |
| June 30, 2018 | 3.939M |
| March 31, 2018 | 2.788M |
| December 31, 2017 | 3.861M |
| September 30, 2017 | 3.771M |
| June 30, 2017 | 3.342M |
| March 31, 2017 | 3.934M |
| December 31, 2016 | 3.63M |
| September 30, 2016 | 4.035M |
| June 30, 2016 | 4.904M |
| March 31, 2016 | 4.911M |
| December 31, 2015 | 4.744M |
| September 30, 2015 | 4.731M |
| June 30, 2015 | 6.058M |
| March 31, 2015 | 5.582M |
| December 31, 2014 | 4.963M |
| September 30, 2014 | 5.264M |
| June 30, 2014 | 4.788M |
| March 31, 2014 | 3.589M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Cocrystal Pharma, Inc. | 3.605M |
| CNBX Pharmaceuticals, Inc. | 2.672M |
| GB Sciences, Inc. | -- |
| Arvinas, Inc. | 112.90M |
| Fulcrum Therapeutics, Inc. | 13.26M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.496M |
| Shareholders Equity (Quarterly) | 6.132M |
| Debt to Equity Ratio | 0.1765 |
| Current Ratio | 0.3932 |
| Net Debt Paydown Yield | -0.60% |